Skip to main content Accessibility help
×
Home

Decreased Cognitive Function in Extended Family Members from the Single Late-Onset-Alzheimer's-Disease Pedigree

  • Yan Zeng (a1), Wei Chang (a2), Chang Shu (a2), Lina Ma (a1), Yuanyuan Huang (a1), Ruoshi Wang (a1), Junpeng Zhang (a1), Changcai Zhu (a2) and Shawn M. McClintock (a3) (a4)...

Abstract

A family history of dementia is associated with an increased risk of developing Alzheimer's disease (AD) late in life (LOAD). This study marked the first attempt to assess the familial contribution to differences in cognitive performance in a large family-based group in the Chinese community. We enrolled 168 participants without dementia from a single pedigree with 9 probable AD patients diagnosed after age 65. These participants were evaluated with a comprehensive neuropsychological battery, the Chinese version of the Mini Mental State Examination, and the Alzheimer Disease Assessment Scale–Cognitive Subscale. Analyses found that extended family members of the LOAD pedigree showed similar performance on measures of global cognitive function and semantic memory compared to controls, but lower scores on episodic memory, attention, and executive function measures. These results indicate that the genetic influences on certain sub-cognitive domains are more detectable despite normal global cognitive function, and that family members with the LOAD pedigree are at risk for developing LOAD by virtue of their family history with an additive risk due to increased age. The findings in this study support the importance of documenting if there is a positive family history of AD in clinical evaluations. (JINS, 2013, 19, 1–11)

Copyright

Corresponding author

Correspondence and reprint requests to: Yan Zeng, Department of Pathophysiology, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China. E-mail: yanzeng11@yahoo.com

References

Hide All
Alzheimer's Association. (2012). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 8(2), 131168.
Albert, M.S. (1996). Cognitive and neurobiologic markers of early Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 93(24), 1354713551.
Albert, M.S., Moss, M.B., Tanzi, R., Jones, K. (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society, 7(5), 631639.
American Psychiatric Association (Pub.) (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition—Text Revision (DSMIV-TR). Washington, DC: American Psychiatric Press, Inc.
Backman, L., Jones, S., Berger, A.K., Laukka, E.J., Small, B.J. (2005). Cognitive impairment in preclinical Alzheimer's disease: A meta-analysis. Neuropsychology, 19(4), 520531.
Backman, L., Small, B.J., Fratiglioni, L. (2001). Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain, 124(Pt 1), 96102.
Baudic, S., Dalla Barba, G., Thibaudet, M.C., Smagghe, A., Remy, P., Traykov, L. (2006). Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Archives of Clinical Neuropsychology, 21(1), 1521.
Bennett, D.A., Wilson, R.S., Boyle, P.A., Buchman, A.S., Schneider, J.A. (2012). Relation of neuropathology to cognition in persons without cognitive impairment. Annals of Neurology, 72(4), 599609.
Bertram, L., Tanzi, R.E. (2012). The genetics of Alzheimer's disease. Progress in Molecular Biology and Transitional Science, 107, 79100.
Bloss, C.S., Delis, D.C., Salmon, D.P., Bondi, M.W. (2008). Decreased cognition in children with risk factors for Alzheimer's disease. Biological Psychiatry, 64(10), 904906.
Bird, T.D. (2005). Genetic factors in Alzheimer's disease. The New England Journal of Medicine, 352, 862864.
Bisiacchi, P.S., Borella, E., Bergamaschi, S., Carretti, B., Mondini, S. (2008). Interplay between memory and executive functions in normal and pathological aging. Journal of Clinical and Experimental Neuropsychology, 30(6), 723733.
Blacker, D., Lee, H., Muzikansky, A., Martin, E.C., Tanzi, R., McArdle, J.J., Albert, M. (2007). Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology, 64(6), 862871.
Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C., Small, G.W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine, 343, 450456.
Bondi, M.W., Jak, A.J., Delano-Wood, L., Jacobson, M.W., Delis, D.C., Salmon, D.P. (2008). Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychology Review, 18(1), 7390.
Bondi, M.W., Salmon, D.P., Galasko, D., Thomas, R.G., Thal, L.J. (1999). Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14(2), 295303.
Bondi, M.W., Salmon, D.P., Monsch, A.U., Galasko, D., Butters, N., Klauber, M.R., Saitoh, T. (1995). Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology, 45(12), 22032206.
Bowie, C.R., Harvey, P.D. (2006). Administration and interpretation of the trail making test. Nature Protocols, 1(5), 22772281.
Braak, E., Arai, K., Braak, H. (1999). Cerebellar involvement in Pick's disease: Affliction of mossy fibers, monodendritic brush cells, and dentate projection neurons. Experimental Neurology, 159, 153163.
Braak, H., Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica (Berl), 82, 239259.
Braak, H., Braak, E. (1996a). Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathologica (Berl), 92, 197201.
Braak, H., Braak, E. (1996b). Evolution of the neuropathology of Alzheimer's disease. Acta Neurologica Scandinavica Supplementary, 165, 312.
Chen, P.J., Ratcliff, G., Belle, S.H., Cauley, J.A., DeKosky, S.T., Ganguli, M. (2001). Patterns of cognitive decline in presymptomatic Alzheimer disease: A prospective community study. Archives of General Psychiatry, 58(9), 853858.
Chiu, H.F., Lee, H.C., Chung, W.S., Kwong, P.K. (1994). Reliability and validity of the Cantonese version of the Mini-Mental State Examination — a preliminary study. Journal of Hong Kong College of Psychiatrists, 2(5), 2528.
Chu, L.W., Chiu, K.C., Hui, S.L., Yu, G.K., Tsui, W.J., Lee, P.W. (2000). The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Annals Academy of Medicine Singapore, 29(4), 474485.
Communiqué of the National Bureau of Statistics of People's Republic of China on Major Figures of the 2010 Population Census (No. 1) (2011, April 28). National Bureau of Statistics of China. Retrieved from http://www.stats.gov.cn/english/newsandcomingevents/t20110428_402722244.htm
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C. Jr., Rimmler, J.B. (1995). Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology, 45, 13231328.
Dickerson, B.C., Sperling, R.A., Hyman, B.T., Albert, M.S., Blacker, D. (2007). Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Archives of General Psychiatry, 64(12), 14431450.
Donix, M., Ercoli, L.M., Siddarth, P., Brown, J.A., Martin-Harris, L., Burggren, A.C., Bookheimer, S.Y. (2012). Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people. The American Journal of Geriatric Psychiatry, 20(7), 565573.
Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association, 278(16), 13491356.
Fine, E.M., Delis, D.C., Wetter, S.R., Jacobson, M.W., Jak, A.J., McDonald, C.R., Bondi, M.W. (2008). Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: A longitudinal study. American Journal of Geriatric Psychiatry, 16(5), 366374.
Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. (1975). A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189198.
Gatz, M., Pedersen, N.L., Berg, S., Johansson, B., Johansson, K., Mortimer, J.A., Ahlbom, A. (1997). Heritability for Alzheimer's disease: The study of dementia in Swedish twins. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52(2), M117M125.
Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Pedersen, N.L. (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63(2), 168174.
Gladsjo, J.A., Schuman, C.C., Evans, J.D., Peary, G.M., Miller, S.W., Heaton, R.K. (1999). Norms for letter and category fluency: Demographic corrections for age, education, and ethnicity. Assessment, 6(2), 147178.
Green, R.C., Cupples, L.A., Go, R., Benke, K.S., Edeki, T., Griffith, P.A., … MIRAGE Study Group. (2002). Risk of dementia among white and African American relatives of patients with Alzheimer disease. Journal of the American Medical Association, 287(3), 329336.
Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., James, L. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349(6311), 704706.
Huang, W., Qiu, C., von Strauss, E., Winblad, B., Fratiglioni, L. (2004). APOE genotype, family history of dementia, and Alzheimer disease risk: A 6-year follow-up study. Archives of Neurology, 61(12), 19301934.
Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., Martin, R.L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566572.
Jack, C.R. Jr., Petersen, R.C., Xu, Y., O'Brien, P.C., Smith, G.E., Ivnik, R.J., Kokmen, E. (2000). Rates of hip-pocampal atrophy correlate with change in clinical status in aging and AD. Neurology, 55(4), 484489.
Johnson, D.K., Storandt, M., Morris, J.C., Galvin, J.E. (2009). Longitudinal study of the transition from healthy aging to Alzheimer disease. Archives of Neurology, 66(10), 12541259.
Johnson, S.C., Schmitz, T.W., Trivedi, M.A., Ries, M.L., Torgerson, B.M., Carlsson, C.M., Sager, M.A. (2006). The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. Journal of Neuroscience, 26(22), 60696076.
Kawas, C.H., Corrada, M.M., Brookmeyer, R., Morrison, A., Resnick, S.M., Zonderman, A.B., Arenberg, D. (2003). Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology, 60(7), 10891093.
Lange, K.L., Bondi, M.W., Galasko, D.G., Delis, D.C., Salmon, D.P., Thal, L.J. (2002). Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of Apolipoprotein E genotype. Journal of the International Neuropsychological Society, 8(7), 943955.
Lee, J.H., Cheng, R., Graff-Radford, N., Foroud, T., Mayeux, R., & National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. (2008). Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: Implication of additional loci. Archives of Neurology, 65(11), 15181526.
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Wang, K. (1995). Candidate gene for the chromosome 1 familial Alzheimer's; disease locus. Science, 269(5266), 973977.
Lindeboom, J., Weinstein, H. (2004). Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, a vascular cognitive impairment. European Journal of Pharmacology, 490(1–3), 8386.
Marshall, G.A., Rentz, D.M., Frey, M.T., Locascio, J.J., Johnson, K.A., Sperling, R.A. (2011). Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimer's Disease Neuroimaging Initiative. Alzheimers & Dementia, 7(3), 300308.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939944.
Morris, J.C., Heyman, A., Mohs, R.C., Hughes, J.P., van Belle, G., Fillenbaum, G., Clark, C. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39(9), 11591165.
Nair, A.K., Gavett, B.E., Damman, M., Dekker, W., Green, R.C., Mandel, A., Stern, R.A. (2010). Clock drawing test ratings by dementia specialists: Interrater reliability and diagnostic accuracy. The Journal of Neuropsychiatry and Clinical Neuroscience, 22(1), 8592.
Perrin, R.J., Fagan, A.M., Holtzman, D.M. (2009). Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature, 461(7266), 916922.
Quental, N.B.M., Brucki, S.M.D., Bueno, O.F.A. (2009). Visuospatial function in early Alzheimer's disease. Dementia & Neuropsychologia, 3(3), 234240.
Reitz, C., Brayne, C., Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nature Review Neurology, 7(3), 137152.
Salmon, D.P., Bondi, M.W. (2009). Neuropsychological assessment of dementia. Annual Review of Psychology, 60, 257282.
Saunders, A.M. (2000). Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses. Journal of Neuropathology Experimental Neurology, 59(9), 751758.
Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., St George-Hyslop, P.H. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375(6534), 754760.
Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B., Backman, L. (2000). The course of cognitive impairment in preclinical Alzheimer disease: Three- and 6-year follow-up of a population-based sample. Archives of Neurology, 57(6), 839844.
Small, G.W., Siddarth, P., Burggren, A.C., Kepe, V., Ercoli, L.M., Miller, K.J., Barrio, J.R. (2009). Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Archives of General Psychiatry, 66(1), 8187.
Sosa-Ortiz, A.L., Acosta-Castillo, I., Prince, M.J. (2012). Epidemiology of dementias and Alzheimer's disease. Archives of Medical Research, 43(8), 600608.
Sperling, R.A., Laviolette, P.S., O'Keefe, K., O'Brien, J., Rentz, D.M., Pihlajamaki, M., Johnson, K.A. (2009). Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron, 63(2), 178188.
St. George-Hyslop, P.H., Petit, A. (2005). Molecular biology and genetics of Alzheimer's disease. Comptes Rendus Biologies, 328(2), 119130.
Storandt, M. (2008). Cognitive deficits in the early stages of Alzheimer's disease. Current Directions in Psychological Science, 17(3), 198202.
Sweet, R.A., Bennett, D.A., Graff-Radford, N.R., Mayeux, R., National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. (2010). Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain, 133(Pt4), 11551162.
Trivedi, M.A., Schmitz, T.W., Ries, M.L., Torgerson, B.M., Sager, M.A., Hermann, B.P., Johnson, S.C. (2006). Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A cross-sectional study. BMC Medicine, 4, 114.
Tsai, R.C., Lin, K.N., Wang, H.J., Liu, H.C. (2007). Evaluating the uses of the total score and the domain scores in the cognitive abilities screening instrument, Chinese version (CASI C-2.0): Results of confirmatory factor analysis. International Psychogeriatrics, 19(6), 10511063.
Wechsler, D. (1987). Wechsler memory scale-revised manual. San Antonio: Psychological Corporation.
Weintraub, S., Wicklund, H.A., Salmon, D.P. (2012). The Neuropsychological profile of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(a006171), 118.
Welsh, K.A., Butters, N., Hughes, J., Mohs, R.C., Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology, 48(3), 278281.
Welsh, K.A., Butters, N., Hughes, J.P., Mohs, R.C., Heyman, A. (1992). Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Archives of Neurology, 49(5), 448452.
Welsh, K.A., Butters, N., Mohs, R.C., Beekly, D., Edland, S., Fillenbaum, G., Heyman, A. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).V. A normative study of the neuropsychological battery. Neurology, 44(4), 609614.
Werheid, K., Hoppe, C., Thone, A., Muller, U., Mungersdorf, M., von Cramon, D.Y. (2002). The Adaptive Digit Ordering Test: Clinical application, reliability, and validity of a verbal working memory test. Archives of Clinical Neuropsychology, 17(6), 547565.
Wilson, R.S., Barral, S., Lee, J.H., Leurgans, S.E., Foroud, T.M., Sweet, R.A., Bennett, D.A. (2011). Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. Journal of Alzheimer's Disease, 23(2), 249255.
Wilson, R.S., Bennett, D.A. (2005). Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology, 25(1), 1925.
Wilson, R.S., Leurgans, S.E., Foroud, T.M., Sweet, R.A., Graff-Radford, N., Mayeux, R., Bennett, D.A., National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group. (2010). Assessment of cognitive function in the Late Onset Alzheimer's Disease Family Study. Archives of Neurology, 67(7), 855861.
Xu, G., McLaren, D.G., Ries, M.L., Fitzgerald, M.E., Bendlin, B.B., Rowley, H.A., Johnson, S.C. (2009). The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain, 132(Pt 2), 383391.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed